炎症性肠病患者随机活检的额外检出率:系统评价与Meta分析
该系统评价与Meta分析纳入37项研究(48个臂)、9051例患者,评估炎症性肠病结肠镜监测中随机活检的额外检出率。按患者和按病变分析的额外检出率分别为10.34%和16.20%,检出率分别为1.31%和2.82%。2011年后启动的研究额外检出率下降,且受原发性硬化性胆管炎比例影响。
要点
- 随机活检按患者和按病变分析的额外检出率分别为10.34%和16.20%。
- 2011年后启动的研究中额外检出率下降,按患者分析从14.43%降至0.42%。
- 原发性硬化性胆管炎比例为100%时,按患者分析的额外检出率达56.05%。
核心结论
- 随机活检按患者和按病变分析的额外检出率分别为10.34%和16.20%。
- 考虑到2011年后启动的研究额外检出率下降及原发性硬化性胆管炎的影响,缺乏全高清设备的内镜中心应考虑将随机活检纳入炎症性肠病患者的标准结肠镜监测,尤其是原发性硬化性胆管炎患者。
研究设计与样本
- 系统评价与Meta分析,检索PubMed、Embase、Web of Science和Cochrane Library,纳入37项研究(48个臂)、9051例患者。
主要发现
- 随机活检按患者分析的额外检出率为10.34%,按病变分析为16.20%。
- 随机活检按患者分析的检出率为1.31%,按病变分析为2.82%。
- 按患者分析,2011年前与2011年后启动的研究额外检出率分别为14.43%和0.42%;按病变分析分别为19.20%和5.32%。
- 按患者分析,原发性硬化性胆管炎比例为0%至10%、10%至30%和100%时,额外检出率分别为4.83%、10.29%和56.05%,检出率分别为0.56%、1.40%和19.45%。
- 按病变分析,原发性硬化性胆管炎比例为0%至10%、10%至30%和100%时,额外检出率分别为11.23%、21.06%和45.22%,检出率分别为2.09%、3.58%和16.24%。
临床怎么用
- 缺乏全高清设备的内镜中心应考虑将随机活检纳入炎症性肠病患者的标准结肠镜监测,尤其是原发性硬化性胆管炎患者。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There are limited clinical data regarding the additional yields of random biopsies (RBs) during colorectal cancer surveillance in patients with inflammatory bowel disease. To assess the additional yield of RB, a systematic review and meta-analysis was conducted. METHODS: PubMed, Embase, Web of Science, and the Cochrane Library were searched for studies investigating the preferred colonoscopy surveillance approach for inflammatory bowel disease patients. The additional yield, detection rate, procedure time, and withdrawal time were pooled. RESULTS: Thirty-seven studies (48 arms) were included in the meta-analysis with 9051 patients. The additional yields of RB were 10.34% in per-patient analysis and 16.20% in per-lesion analysis. The detection rates were 1.31% and 2.82% in per-patient and per-lesion analysis, respectively. Subgroup analysis showed a decline in additional yields from 14.43% to 0.42% in the per-patient analysis and from 19.20% to 5.32% in the per-lesion analysis for studies initiated before and after 2011. In per-patient analysis, the additional yields were 4.83%, 10.29%, and 56.05% for primary sclerosing cholangitis (PSC) proportions of 0% to 10%, 10% to 30%, and 100%, respectively. The corresponding detection rates were 0.56%, 1.40%, and 19.45%. In the per-lesion analysis, additional yields were 11.23%, 21.06%, and 45.22% for PSC proportions of 0% to 10%, 10% to 30%, and 100%, respectively. The corresponding detection rates were 2.09%, 3.58%, and 16.24%. CONCLUSIONS: The additional yields of RB were 10.34% and 16.20% for per-patient and per-lesion analyses, respectively. Considering the decreased additional yields in studies initiated after 2011, and the influence of PSC, endoscopy centers lacking full high-definition equipment should consider incorporating RB in the standard colonoscopy surveillance for inflammatory bowel disease patients, especially in those with PSC.
引用
- Gao L, Fang K, Dong X, et al. Additional Yield of Random Biopsy in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Clin Gastroenterol Hepatol. 2024. PMID: 38972436. doi:10.1016/j.cgh.2024.05.045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。